NSE - Delayed Quote INR
Bal Pharma Limited (BALPHARMA.NS)
107.14
-1.75
(-1.61%)
At close: April 25 at 3:29:26 PM GMT+5:30
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Operating Cash Flow
--
228,058
-15,371
267,955
223,352
Investing Cash Flow
--
-188,909
-221,824
-94,848
-55,345
Financing Cash Flow
--
-12,063
240,938
-172,215
-166,324
End Cash Position
--
41,958
14,871
11,126
10,234
Capital Expenditure
--
-109,800
-146,454
-84,693
-33,644
Issuance of Capital Stock
--
5,012
39,171
9,128
41,875
Issuance of Debt
--
58,263
117,021
30,813
40,000
Repayment of Debt
--
--
--
--
-36,637
Free Cash Flow
--
118,258
-161,825
183,262
189,708
3/31/2021 - 5/8/2006
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
THEMISMED.NS Themis Medicare Limited
133.54
-3.60%
INDSWFTLAB.NS Ind-Swift Laboratories Limited
80.51
-6.17%
RPGLIFE.NS RPG Life Sciences Limited
2,244.30
-3.82%
SYNCOMF.NS Syncom Formulations (India) Limited
17.04
-5.18%
SPARC.NS Sun Pharma Advanced Research Company Limited
149.77
-3.37%
SIGACHI.NS Sigachi Industries Limited
42.84
-5.72%
MOREPENLAB.NS Morepen Laboratories Limited
58.82
-5.46%